Himalaya Nutravedics India Limited
BBSE:HNIL137.20
INR
+13.65
(+11.05%)
Himalaya Nutravedics India Limited
BSE:HNIL
(Bombay Stock Exchange)
Recent
price
137.20
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Himalaya Nutravedics India Limited is an India-based pharmaceutical and wellness company engaged in the research, development, manufacturing, marketing, and distribution of Ayurvedic, herbal, and nutraceutical products. The company operates through a hybrid business model comprising the commercialization of proprietary branded wellness formulations alongside third-party contract manufacturing and loan licensing services for external healthcare brands. Its product portfolio spans various dosage forms and therapeutic categories, including soft gelatin capsules; hard gelatin capsules; solid oral dosage tablets; liquid oral syrups and suspensions; medicated herbal oils; dietary protein powders; botanical extracts; and classical Ayurvedic (Shastric) formulations. These products target diverse therapeutic areas, such as digestive and gastrointestinal health; joint care and musculoskeletal pain management; metabolic health; immune system enhancement; neurological support; dermatological care; male wellness; and women's health, marketed under brand and formulation names such as Himarex, Heelsage, Ligasage, Cervisage, Lumbasage, Guggulu Tiktha Gritham, and Atasi Tailam. The company operates an integrated manufacturing facility located in Cherlapally, Hyderabad, Telangana, which complies with WHO-GMP standards and maintains certifications including ISO 9001:2015, HACCP, Halal, and Kosher. Himalaya Nutravedics India Limited serves both business-to-business (B2B) institutional clients and business-to-consumer (B2C) retail markets across India. Originally incorporated in June 2022 as Himalaya Nutravedics India Private Limited, the company is headquartered in Hyderabad, Telangana, India. In November 2025, the company underwent a corporate restructuring and converted from a private limited company into a public limited company, adopting its current name. In September 2026, Himalaya Nutravedics India Limited completed its Initial Public Offering (IPO) on the BSE SME platform, raising 26.50 crore rupees through a fresh issue of equity shares, with official listing and trading commencing on the Bombay Stock Exchange under the ticker HNIL (Scrip Code: 544943). The company deployed the capital proceeds to fund working capital requirements, augment production capacities at its Cherlapally manufacturing base, scale its digital marketing and omnichannel distribution channels, and broaden its third-party contract manufacturing alliances.